缩写名/全名 |
LANCET ONCOL
LANCET ONCOLOGY |
||||||||||||||||
ISSN号 | 1470-2045 | ||||||||||||||||
研究方向 | 医学-肿瘤学 | ||||||||||||||||
影响因子 | 2015:26.509, 2016:33.9, 2017:36.418, 2018:35.386, 2019:33.752, | ||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||
出版周期 | Monthly | ||||||||||||||||
年文章数 | 167 | ||||||||||||||||
出版年份 | 2000 | ||||||||||||||||
是否OA | No | ||||||||||||||||
审稿周期(仅供参考) | 一般,3-8周 |
||||||||||||||||
录用比例 | 极难 | ||||||||||||||||
投稿链接 | http://ees.elsevier.com/thelancetoncology/ | ||||||||||||||||
投稿官网 | http://www.thelancet.com/journals/lanonc/issue/current | ||||||||||||||||
h-index | 274 | ||||||||||||||||
CiteScore |
|
||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1470-2045%5BISSN%5D | ||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Deep convolutional neural network models for the diagnosis of thyroid cancer – Authors' reply Author: Xiangchun Li, Sheng Zhang, Qiang Zhang, Xi Wei, Ming Gao, Wei Zhang, Kexin Chen Journal: LANCET ONCOLOGY, 2019, Vol.20, e131, DOI:10.1016/s1470-2045(19)30083-x DOI |
2. | Pazopanib in the treatment of advanced solitary fibrous tumour Author: Chao Tu, Xiaolei Ren, Jieyu He, Chenghao Zhang, Zhihong Li Journal: LANCET ONCOLOGY, 2019, Vol.20, e127, DOI:10.1016/s1470-2045(19)30030-0 DOI |
3. | Deep convolutional neural network models for the diagnosis of thyroid cancer Author: Dan Hu, Feng Peng, Wenquan Niu Journal: LANCET ONCOLOGY, 2019, Vol.20, e129, DOI:10.1016/s1470-2045(19)30025-7 DOI |
4. | DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how? Author: Ka On Lam, Chi Chung Tong, Victor Ho Fun Lee, Mai Yee Luk, Ching Wan Lam Journal: LANCET ONCOLOGY, 2019, Vol.20, e66, DOI:10.1016/s1470-2045(18)30867-2 DOI |
5. | Challenges in anticancer drug R&D in China Author: Shen Zhao, Cheng Lv, Jifang Gong, Fang Wenfeng, Xichun Hu, Yi Ba, Chen Xiaoyuan, Yang Zhimin, Lin Shen, Li Zhang Journal: LANCET ONCOLOGY, 2019, Vol.20, 183-186, DOI:10.1016/s1470-2045(18)30865-9 DOI |
6. | One-view breast tomosynthesis vs two-view mammography: a methodological issue Author: Xiang Fang, Weili Kong, Jianqing Qiu, Zeping Yu, Hong Duan Journal: LANCET ONCOLOGY, 2019, Vol.20, e6, DOI:10.1016/s1470-2045(18)30811-8 DOI |
7. | Lung squamous carcinoma involving the lip and cheek Author: Binjie Yan, Fang Wu, Nong Yang, Yongchang Zhang Journal: LANCET ONCOLOGY, 2018, Vol.19, e726, DOI:10.1016/s1470-2045(18)30441-8 DOI |
8. | Maternal use of hormonal contraception and risk of childhood leukaemia Author: Yubin Cao, Chunjie Li, Longjiang Li Journal: LANCET ONCOLOGY, 2018, Vol.19, e657, DOI:10.1016/s1470-2045(18)30810-6 DOI |
9. | Common analgesics and ovarian cancer prognosis Author: Jianzheng Jie, Wenquan Niu Journal: LANCET ONCOLOGY, 2018, Vol.19, e505, DOI:10.1016/s1470-2045(18)30572-2 DOI |
10. | Follow-up surveillance of Wilms' tumour Author: Guohui Fan, Qian Zhang Journal: LANCET ONCOLOGY, 2018, Vol.19, e501, DOI:10.1016/s1470-2045(18)30529-1 DOI |
|
|